Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Elevated cyclin E level in human clear cell renal cell carcinoma: possible causes and consequences.
Acta Biochim Pol. 2007;54(3):595-602. Epub 2007 Aug 28.
Acta Biochim Pol. 2007.
PMID: 17726548
Thyroid hormones and their receptors in the regulation of cell proliferation.
Puzianowska-Kuznicka M, Pietrzak M, Turowska O, Nauman A.
Puzianowska-Kuznicka M, et al. Among authors: turowska o.
Acta Biochim Pol. 2006;53(4):641-50. Epub 2006 Nov 19.
Acta Biochim Pol. 2006.
PMID: 17115080
Review.
Item in Clipboard
Overexpression of E2F1 in clear cell renal cell carcinoma: a potential impact of erroneous regulation by thyroid hormone nuclear receptors.
Turowska O, Nauman A, Pietrzak M, Popławski P, Master A, Nygard M, Bondesson M, Tanski Z, Puzianowska-Kuznicka M.
Turowska O, et al.
Thyroid. 2007 Nov;17(11):1039-48. doi: 10.1089/thy.2007.0075.
Thyroid. 2007.
PMID: 17910524
Item in Clipboard
[Genetic adrenal diseases].
Turowska O, Ferenc T, Lewiński A.
Turowska O, et al.
Postepy Hig Med Dosw (Online). 2004;58:506-13.
Postepy Hig Med Dosw (Online). 2004.
PMID: 15765012
Review.
Polish.
Item in Clipboard
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators.
Gerstein HC, et al.
Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9.
Lancet. 2019.
PMID: 31189511
Clinical Trial.
Item in Clipboard
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators.
Gerstein HC, et al.
Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9.
Lancet. 2019.
PMID: 31189509
Clinical Trial.
Item in Clipboard
Cite
Cite